Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 188

1.

HIV-1 Tat-mediated activation of glycogen synthase kinase-3beta contributes to Tat-mediated neurotoxicity.

Maggirwar SB, Tong N, Ramirez S, Gelbard HA, Dewhurst S.

J Neurochem. 1999 Aug;73(2):578-86.

2.

Activation of glycogen synthase kinase 3 beta (GSK-3beta) by platelet activating factor mediates migration and cell death in cerebellar granule neurons.

Tong N, Sanchez JF, Maggirwar SB, Ramirez SH, Guo H, Dewhurst S, Gelbard HA.

Eur J Neurosci. 2001 May;13(10):1913-22.

PMID:
11403684
3.

Inhibition of mixed lineage kinase 3 prevents HIV-1 Tat-mediated neurotoxicity and monocyte activation.

Sui Z, Fan S, Sniderhan L, Reisinger E, Litzburg A, Schifitto G, Gelbard HA, Dewhurst S, Maggirwar SB.

J Immunol. 2006 Jul 1;177(1):702-11.

4.
5.

Glycogen synthase kinase-3 is involved in the regulation of the cell cycle in cerebellar granule cells.

Yeste-Velasco M, Folch J, Trullàs R, Abad MA, Enguita M, Pallàs M, Camins A.

Neuropharmacology. 2007 Aug;53(2):295-307.

PMID:
17612578
6.
9.

Dual regulation of glycogen synthase kinase-3beta by the alpha1A-adrenergic receptor.

Ballou LM, Tian PY, Lin HY, Jiang YP, Lin RZ.

J Biol Chem. 2001 Nov 2;276(44):40910-6.

10.

Neurotrophins prevent HIV Tat-induced neuronal apoptosis via a nuclear factor-kappaB (NF-kappaB)-dependent mechanism.

Ramirez SH, Sanchez JF, Dimitri CA, Gelbard HA, Dewhurst S, Maggirwar SB.

J Neurochem. 2001 Aug;78(4):874-89.

11.
12.

GSK-3beta negatively regulates skeletal myotube hypertrophy.

Vyas DR, Spangenburg EE, Abraha TW, Childs TE, Booth FW.

Am J Physiol Cell Physiol. 2002 Aug;283(2):C545-51.

13.

Tat protein from HIV-1 activates MAP kinase in granular neurons and glial cells from rat cerebellum.

Menegon A, Leoni C, Benfenati F, Valtorta F.

Biochem Biophys Res Commun. 1997 Sep 29;238(3):800-5.

PMID:
9325171
14.

The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3.

Chen G, Huang LD, Jiang YM, Manji HK.

J Neurochem. 1999 Mar;72(3):1327-30.

15.

Role of glycogen synthase kinase-3 in TNF-alpha-induced NF-kappaB activation and apoptosis in hepatocytes.

Schwabe RF, Brenner DA.

Am J Physiol Gastrointest Liver Physiol. 2002 Jul;283(1):G204-11.

16.
17.
18.

Human immunodeficiency virus-encoded Tat activates glycogen synthase kinase-3beta to antagonize nuclear factor-kappaB survival pathway in neurons.

Sui Z, Sniderhan LF, Fan S, Kazmierczak K, Reisinger E, Kovács AD, Potash MJ, Dewhurst S, Gelbard HA, Maggirwar SB.

Eur J Neurosci. 2006 May;23(10):2623-34.

PMID:
16817865
19.

Inhibition of glycogen synthase kinase 3beta activity regulates proliferation of cultured cerebellar granule cells.

Cui H, Meng Y, Bulleit RF.

Brain Res Dev Brain Res. 1998 Dec 7;111(2):177-88.

PMID:
9838099
20.

The synthesis of platelet-activating factor modulates chemotaxis of monocytes induced by HIV-1 Tat.

Del Sorbo L, DeMartino A, Biancone L, Bussolati B, Conaldi PG, Toniolo A, Camussi G.

Eur J Immunol. 1999 May;29(5):1513-21.

Items per page

Supplemental Content

Support Center